Tohru Tanaka

This inventor holds 18 USPTO granted patents and 1 published patent application, plus 12 CIPO patents and 4 EPO patents. Top assignees: Cosmo Oil Co., Ltd., Cosmo Research Institute, Sbi Pharmaceuticals Co., Ltd.. Active years: 1994-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tohru Tanaka. Retrieved from https://idiyas.com/inventor/tohru-tanaka-67d57dfe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 12 (Patent Applications = 1)

EPO Patents = 4

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 132(Granted Patents)

Location History:

Matsudo, JP (2002 - 2004)
Kita-adachi-gun, JP (2015)
Minato-ku, JP (2007 - 2016)
Saitama, JP (1994 - 2017)

Company Filing History:

Cosmo Research Institute

patents

5 out of 41

Sbi Pharmaceuticals Co., Ltd.

5. 3 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2017

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9730904 - Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient (2017-08-15),

2. 9340490 - Diagnostic agent for tumor (2016-05-17),

3. 9095165 - Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient (2015-08-04),

4. 8999296 - Method of detecting bladder cancer (2015-04-07),

5. 8790712 - Constitutional function-improving agents (2014-07-29),

6. 8173839 - 5-aminolevulinic acid salt, process for producing the same and use thereof (2012-05-08),

7. 7220779 - Swine growth promoters and method of promoting swine growth (2007-05-22),

8. 7135162 - Agent for diagnosing and treating malignant tumors (2006-11-14),

9. 6905671 - Diagnostic agents and remedies for malignant tumors (2005-06-14),

10. 6797199 - Clathrate compounds, manufacture thereof, and thermoelectric materials, thermoelectric modules, semiconductor materials and hard materials based thereon (2004-09-28),

11. 6461581 - Clathrate compounds and manufacturing method thereof (2002-10-08),

12. 6342377 - Microorganisms producing 5-aminolevulinic acid and processes for producing 5-aminolevulinic acid by using the same (2002-01-29),

13. 5763235 - 5-aminolevulinic acid producing microorganism and process for producing (1998-06-09),

14. 5733770 - 5-aminolevulinic acid producing microorganism and process for producing (1998-03-31),

15. 5661111 - Method for improving plant salt-tolerance (1997-08-26),

Title: The Innovative Inventions of Tohru Tanaka

Introduction

Tohru Tanaka, an accomplished inventor based in Saitama, Japan, is renowned for his contributions to the field of pharmaceuticals and medical diagnostics. With a prolific portfolio of 18 patents, Tohru's work primarily focuses on developing agents that address various adult diseases, improving the quality of life for many individuals.

Latest Patents

Tohru Tanaka's recent patents showcase innovative approaches to treating and diagnosing adult diseases. His notable works include a prophylactic agent containing 5-aminolevulinic acid and its derivatives, aimed at ameliorating conditions such as metabolic syndrome, diabetes, and hypertension. This pharmaceutical composition functions by improving basal metabolism without side effects or the risk of drug resistance, offering an alternative to existing therapeutic agents. Additionally, his diagnostic agent for tumors employs a unique mechanism involving the measurement of porphyrins in samples to facilitate early detection and monitoring of therapeutic effects across various tumor types.

Career Highlights

Tohru's career includes significant contributions to esteemed organizations such as Cosmo Oil Co., Ltd. and the Cosmo Research Institute. Throughout his tenure, he has dedicated himself to advancing medical science, particularly in areas affecting adult health. His innovations have positioned him as a leader in pharmaceutical research and development.

Collaborations

In his journey as an inventor, Tohru has collaborated with distinguished professionals, including Yasushi Hotta and Seiji Nishikawa. These partnerships have played a crucial role in fostering innovation and enhancing the scope of his research, leading to groundbreaking inventions that address pressing health concerns.

Conclusion

In summary, Tohru Tanaka's inventive spirit and dedication to improving adult health through innovative therapies and diagnostic tools make him a prominent figure in the field of pharmaceuticals. His commitment to research continues to inspire advancements that hold the potential for significant impact on health outcomes worldwide.

Profile summary based on public USPTO records.